Page 331 - Binder2
P. 331

●  Sterile fill-finish: The purified protein is filtered,
                       transferred into sterile vials or syringes, labeled,
                       packaged, and stored—typically under cold-chain
                       conditions.


               The result? A cost of goods that can easily reach hundreds
               to thousands of dollars per gram, even before accounting
               for distribution, administration, or regulatory overhead.


               This complexity has become accepted—not because it’s
               efficient, but because it’s necessary in a system built around
               injectable, purified proteins made in mammalian cells.




               Compare That to the Grow Room


               Now enter the plant-based model.

               Instead of a 15,000-liter bioreactor, imagine a 15,000-
               square-foot grow room. The therapeutic gene isn’t inserted
               into animal cells—it’s engineered into a fast-growing plant
               like lettuce, rice, or duckweed. These plants act as living
               bioreactors, using photosynthesis to convert sunlight,
               water, and nutrients into high-value proteins.

                   ●  After several days or weeks of growth, the leaves
                       are harvested—just like any agricultural crop.
                   ●  The plant material is freeze-dried, locking in the
                       protein and stabilizing it for storage.
                   ●  It is then milled into a fine powder and encapsulated
                       into oral capsules.

               That’s it.





                                          329
   326   327   328   329   330   331   332   333   334   335   336